Sun Pharma shines as its arm to acquire balance 25% outstanding shares in Sun Pharma de Mexico
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Sun Pharmaceutical Industries is currently trading at Rs. 1162.70, up by 30.55 points or 2.70% from its previous closing of Rs. 1132.15 on the BSE.
The scrip opened at Rs. 1148.00 and has touched a high and low of Rs. 1167.00 and Rs. 1135.50 respectively. So far 31498 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1169.90 on 03-Aug-2023 and a 52 week low of Rs. 921.25 on 29-Sep-2022.
Last one week high and low of the scrip stood at Rs. 1167.00 and Rs. 1118.40 respectively. The current market cap of the company is Rs. 277938.96 crore.
The promoters holding in the company stood at 54.48%, while Institutions and Non-Institutions held 36.23% and 9.29% respectively.
Sun Pharmaceutical Industries’ wholly-owned Subsidiary -- Sun Pharma (Netherlands) B.V. has signed a binding letter of intent to acquire the balance 25% outstanding shares of Sun Pharma de Mexico, S.A. de C.V., a subsidiary of the Company, where the Company is currently holding 75% shares.
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de Mexico, S.A. de C.V. becoming a wholly-owned subsidiary of the Company.
Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.
